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CONFERENCIA PLENARIA
“If I have seen farther it is by standing on the shoulders of 
giants” (Isaac Newton).
This famous phrase, written by Isaac Newton in a letter 
addressed to Robert Hook in 1676, expresses with splendid 
exactitude the scientific ideal: science must be cumulative so 
that each new discovery must depends on and be based on 
previous research and knowledge.
In fact, scientists believe that new research is better, or more 
insightful or more powerful. This thinking assumes that the 
new studies will incorporate and improve the lessons learned 
from previous work. The novelty itself is superficial without 
links to the past. Each new result must be interpreted in the 
context of previous research.
Consequently, for science to be cumulative, an intermediate 
step between past and future research is necessary. The new 
scientific ideal must be that new primary studies were based 
on systematic reviews of previous similar studies, that is, in 
synthesis of the existing evidence (1).
Strictly speaking, the scientific logic leads us to think that it 
seems unlikely that the study reports (scientific articles) have 
been published without taking into account all the relevant 
previous research, or at least that these articles have not 
been published in high impact journals. However, an article 
published in 2011 (2) throws worrying data on how often 
authors refer to the totality of earlier research. After the 
evaluation of 227 meta-analyzes that included a total of 1523 
randomized controlled trials (RCTs), it was shown that 55% 
of the authors did not reference any trials, and the median 
number of references to earlier studies was 2 even though 
they could have cited 3 or more studies from the same area. 
These data reflect an important problem: the systematic and 
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By building the new research on the existing body of evidence 
and presenting the results in the context of previous results, 
the evidence-based research approach helps to:  
•	 avoid waste in research by making research more 
relevant, more ethical and more valuable; 
•	 reduce false positives (type 1 error) and medical reversals; 
•	 concentrate the money spent on research to improve the 
allocation of resources; 
•	 make better evidence available to facilitate adequately 
informed choices; 
•	 improve how clinical trials are reported in the media; 
•	 restore the end user’s confidence in the investigation.
Stakeholders (especially clinical researchers) will need to 
invest in learning the knowledge and skills to carry out 
evidence-based research, however, they will gain a more 
interesting and relevant research.
In 1994, Professor Doug Altman stated that “We need less 
research, better research, and research done for the right 
reasons” (6). By promoting that research should have value 
for society and scientifically, Evidence-Based Research will 
help make this a reality.
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transparent approach is rarely used when referencing to 
similar previous trials.
A 2018 publication (3) offers more information about whether 
systematic reviews of existing studies are used to see if a new 
study is required. The review, after the evaluation of 622 RCTs 
published in high impact journals in anesthesiology (2014-
2016), concludes that only 20% of RCTs cite a systematic 
review (SR) as justification for new studies on the subject, and 
44% do not cite any SR, which reflects another problem closely 
related to the aforementioned: a systematic and transparent 
approach is rarely used to justify additional studies.
A third article published in 2015 (4) that evaluated whether 
previous systematic reviews have an influence on research 
agendas, concludes that despite 77% of the 47 trials evaluated 
(trials funded by the National Institute for the Evaluation of 
Health Technology for Health Research - NIHR HTA between 
2006 and 2008) referred to a previous SR, only 42% used 
the information from these reviews to design and plan a new 
study, which in turn reflects another problem: a systematic 
and transparent approach is rarely used to design new 
studies.
Another publication of 2013 (5) that evaluated the frequency 
with which scientific authors place their results in the context 
of previous research, concluded that most of the randomized 
studies published in May 1997, 2001, 2005, 2009 and 2012 
in the 5 leading high-impact journals, did not attempt to 
place their results in the context of previous research, which 
again suggests that: systematic and transparent approach 
are rarely used when placing new results in the context of 
existing results from earlier similar trials.
At this point, some concerns arise regarding these results. 
Undertaking new research without systematically reviewing 
the evidence of what is already known, particularly when it 
involves people or animals, is unethical, is unscientific and 
is wasteful. Although most of the clinical researchers refer 
to previous studies and try to do it correctly, evidence show 
however, that researchers, research funders, regulators, 
sponsors and publishers of research fail to use earlier research 
when preparing to initiate, fund, regulate, sponsor or publish 
the results of new studies.
Consequently, the suggested solution to this concerns is to 
implement “systematisity” and “transparency” in all phases 
of research to ensure that the research is valuable, i.e. 
“relevant” and “necessary”.
To achieve this, an international group of researchers 
established the Evidence-Based Research Network 
(EBRNetwork) in Bergen, Norway in December 2014. In 2018 
the EBRNetwork got support to establish EVBRES a COST 
Action funded by the EU for 4 years (2018-2022) aimed at 
creating an international European-based network to raise 
awareness of the need to use systematic reviews when 
planning new studies and when placing new results in context. 
The sustainability of EVBRES is ensured by the EBRNetwork. re
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